feed,title,long_url,short_url
Benzinga,Targovax and Papyrus Therapeutics enter research collaboration to develop novel ONCOS viruses with receptor tyrosine kinase (RTK) inhibitor functionality,https://www.benzinga.com/pressreleases/21/02/n19579581/targovax-and-papyrus-therapeutics-enter-research-collaboration-to-develop-novel-oncos-viruses-with,https://j.mp/3q6IeMz
